Lv55
810 积分 2022-04-14 加入
[Toripalimab in combination with cisplatin and gemcitabine in recurrent or metastatic nasopharyngeal carcinomas (UCNT RM) in first-line treatment]
4小时前
求助中
Effect of Early Tumor Shrinkage and Depth of Response on the Clinical Outcomes of Patients with Unresectable Hepatocellular Carcinoma Treated with Transcatheter Arterial Chemoembolization and Lenvatinib Plus PD-1 Inhibitors
4小时前
求助中
Efficacy and safety of autologous CIK cell therapy plus Toripalimab with or without chemotherapy in advanced NSCLC: A phase II study
4小时前
已完结
Efficacy and safety of autologous CIK cell therapy plus Toripalimab with or without chemotherapy in advanced NSCLC: A phase II study
4小时前
已关闭
Deucravacitinib onset of action and maintenance of response in phase 3 plaque psoriasis trials
11小时前
已完结
Long‐term real‐world effectiveness of deucravacitinib in psoriasis: A 52‐week prospective study stratified by prior apremilast or biologic therapy
11小时前
已完结
Real‐world 52‐week effectiveness of deucravacitinib in psoriasis: A stratified analysis by age and body mass index
11小时前
已完结
Pathogenesis and treatment of psoriasis: exploiting pathophysiological pathways for precision medicine
1天前
已完结
An Overview of Contemporary and Future Therapeutic Strategies for Scalp Psoriasis
1天前
已完结
皖公网安备34019202002308
